Introduction {#sec1}
============

Since the discovery of adult neural stem cells (aNSCs), the extent to which stem cells have common hallmarks, either in the same tissue from development into adulthood or across different adult tissues, has been a key issue. The transcription factor SOX2, the intermediate filament protein Nestin, and the membrane protein Prominin1 have been suggested as common molecular markers for NSCs across different regions and ontogenies ([@bib18; @bib32; @bib34]). However, these markers are rather widespread in the adult brain, with SOX2 being expressed in all astrocytes ([@bib32]) and Nestin and Prominin1 present in all ependymal cells lining the ventricle ([@bib1; @bib6]).

To overcome the problems associated with the promiscuity of a single marker, we previously applied a combinatorial approach to detect and isolate radial glial cells (i.e., NSCs) in developing and adult mouse brains ([@bib9; @bib16]) by their glial identity (e.g., GLAST ([@bib23]), GFAP ([@bib20]), and human GFAP \[hGFAP\]-eGFP) and coexpression of Prominin1 ([@bib25; @bib1]), a membrane-associated glycoprotein that is expressed in neurogenic regions of other vertebrates with widespread neurogenesis ([@bib13]). This approach allowed not only purification of NSCs in the developing brain ([@bib25]) but also enrichment of aNSCs from the subependymal zone (SEZ; [@bib1]).

Little is known about Prominin1 localization on adult NSCs in the dentate gyrus (DG), the only region where neurogenesis appears to persist prominently in the adult human brain ([@bib27; @bib30]). Although Prominin1 is present in neurosphere-forming cells from the adult murine hippocampus ([@bib33]), the relationship of Prominin1 with GFAP+ radial and horizontal astrocytes that act as NSCs in this region ([@bib19]) is less well understood. Here, we examined the extent of Prominin1 and GFAP coexpression in aNSCs in murine and human DG, and monitored the progeny of these cells by genetic fate mapping.

Results {#sec2}
=======

Prominin1 Is Expressed in Radial and Nonradial Glial Cells in the Subgranular Zone of the Adult Hippocampus {#sec2.1}
-----------------------------------------------------------------------------------------------------------

Prominin1 maps to loci that promote neurogenesis in the DG ([@bib15]), and was recently shown to be expressed in most neurosphere-forming cells of the hippocampus ([@bib33]). To examine the colocalization of Prominin1 with GFAP, we immunostained adult hippocampal sections of hGFAP-eGFP transgenic mice. Interestingly, we found that Prominin1 immunoreactivity was restricted to the DG ([Figure 1](#fig1){ref-type="fig"}A), where it localized along the radial process and soma of radial astrocytes ([Figure 1](#fig1){ref-type="fig"}A), horizontal astrocytes in the subgranular zone (SGZ), and some astrocytes in the hilus. Prominin1+ radial astrocytes showed high levels of hGFAP-eGFP ([Figure 1](#fig1){ref-type="fig"}A) and coexpressed endogenous GFAP ([Figure 1](#fig1){ref-type="fig"}B), Nestin ([Figure 1](#fig1){ref-type="fig"}C), and SOX2 ([Figure 1](#fig1){ref-type="fig"}E). All Nestin-immunoreactive radial astrocytes were positive for Prominin1, while 40% of the radial astrocytes expressed both Prominin1 and hGFAP-eGFP. Very few Prominin1+/hGFAP-eGFP+ cells were positive for S100β, which labels postmitotic astrocytes, and no colocalization with the intermediate progenitor (IP) marker TBR2 ([Figure S1](#app2){ref-type="sec"}A available online) or the neuroblast (NB) marker Doublecortin (DCX) was detectable ([Figure 1](#fig1){ref-type="fig"}D; summarized in [Figure 1](#fig1){ref-type="fig"}F). hGFAP-eGFP+ cells that lacked Prominin1 comprised many other cell types, such as parenchymal astrocytes in the molecular layer (ML), the granular zone (GZ), and the hilus (GFAP in [Figure 1](#fig1){ref-type="fig"}B), and were S100β immunoreactive ([Figure 1](#fig1){ref-type="fig"}F), consistent with a more mature astrocyte identity ([@bib26]). A small proportion of DCX+ NBs and immature neurons ([Figure 1](#fig1){ref-type="fig"}D) were Prominin1− and had weaker GFP signals than radial and other astrocytes, consistent with the idea that they inherited the GFP from their ancestors but had turned off the activity of the hGFAP promoter ([@bib1; @bib25]). We also observed Prominin1+ radial cells that were negative for hGFAP-eGFP and DCX, but positive for GFAP ([Figure 1](#fig1){ref-type="fig"}B), Nestin ([Figure 1](#fig1){ref-type="fig"}C), and SOX2 ([Figure 1](#fig1){ref-type="fig"}F). In the SGZ, Prominin1+/hGFAP-eGFP+ cells consisted of radial and horizontal astrocytes coexpressing aNSC proteins such as SOX2 and Nestin, whereas the population that was positive for only one of the markers comprised many more cell types within and beyond the DG.

Prominin1+/hGFAP-eGFP+ Cells Are Bromodeoxyuridine-Label Retaining in the Adult Murine DG {#sec2.2}
-----------------------------------------------------------------------------------------

Next, we examined the extent to which the Prominin1+/hGFAP-eGFP+ cells were bromodeoxyuridine (BrdU)-label retaining, which is a property of slow-dividing aNSCs ([@bib19]). BrdU was provided in drinking water for hGFAP-eGFP mice (2 weeks to 2 months old) to label the cells that divided in this time window, followed by a 2 week BrdU-free chase period. In this paradigm, slow-dividing aNSCs and postmitotic progeny such as neurons are labeled, but the latter can be distinguished by costaining for neuronal markers. Indeed, most of the BrdU-labeled cells were positive for DCX (76%, n = 242 BrdU+ cells, 4 animals), indicative of an NB or immature neuron identity ([Figure 2](#fig2){ref-type="fig"}A), whereas some BrdU+ cells expressed GFAP ([Figure 2](#fig2){ref-type="fig"}B). We found that 3% of the BrdU-label-retaining cells (n = 845 BrdU+ cells, 4 animals) were Prominin1+/hGFAP-eGFP+ ([Figures 2](#fig2){ref-type="fig"}C and 2D). Conversely, 29.8% of the Prominin1+/hGFAP-eGFP+ radial astrocytes retained the BrdU label, consistent with their slow mode of cell division (n = 120 Prominin1+/hGFAP-eGFP+ cells, 4 animals). Some BrdU+ cells were colabeled with either Prominin1 or hGFAP-eGFP alone (3.9% and 4.4%, respectively; [Figure 2](#fig2){ref-type="fig"}C; n = 845 BrdU+ cells, 4 animals). The latter category comprised DCX+ cells as well as GFAP+ astrocytes, consistent with the finding that some dividing aNSCs can give rise to astrocytes ([@bib7]). Few BrdU-label-retaining cells coexpressed the cell-cycle marker KI67, implying that they reentered the cell cycle ([Figure 2](#fig2){ref-type="fig"}E). Since these cells were hGFAP-eGFP+ with long radial processes that were always labeled with Prominin1 ([Figure 1](#fig1){ref-type="fig"}A), we conclude that this population is BrdU-label retaining and represents self-renewing aNSCs.

In Vivo Targeting of aNSCs in the DG by a Split-Cre Approach {#sec2.3}
------------------------------------------------------------

Next, we performed a fate-mapping analysis of Prominin1+/hGFAP+ cells to assess lineage and self-renewal. For this purpose, we employed the split-Cre approach ([@bib11]), in which the C-terminal half of the Cre recombinase is driven by the Prominin1 P2 promoter and inserted into one lentiviral vector, while the N-terminal half of Cre is driven by hGFAP promoter elements and inserted into a second lentiviral vector ([@bib1]). We injected the two lentiviruses into the DG of 2-month-old CAG CAT GFP reporter mice and assessed the identity of the recombined cells by immunohistochemistry along with morphological criteria and localization. The recombined cells were analyzed shortly after the injection (3 days postinjection \[dpi\]) to determine their identity and at later time points (7 dpi, and 1 and 3 months postinjection \[mpi\]) to monitor their progeny. At 3 dpi, the majority of the reporter-positive cells were GFAP+ (88.2%; n = 272 GFP+ cells in 3 different animals). In the SGZ, the majority of GFP+/GFAP+ cells had a radial or horizontal morphology ([Figures 3](#fig3){ref-type="fig"}A and 3B; [Table S1](#app2){ref-type="sec"}) consistent with the suggestion that the DG contains morphologically distinct aNSC populations ([@bib19]). We also observed some GFP+ astrocytes in the hilus and GZ ([Figures 3](#fig3){ref-type="fig"}A and 3B; [Table S1](#app2){ref-type="sec"}), similar to the results from immunostaining described above, and very few in the ML. At this early time point and 7 dpi (data not shown), none of the recombined cells were colabeled with TBR2 ([Figure S1](#app2){ref-type="sec"}B; [Table S1](#app2){ref-type="sec"}) or DCX ([Table S1](#app2){ref-type="sec"}), showing that the starting population does not comprise the progeny of aNSCs, as previously indicated by other approaches ([@bib2; @bib17]). It also reveals that the labeled aNSCs were largely quiescent, as their progeny 7 days after labeling had not yet passed to the early steps of the neuronal lineage, such as IPs and early NBs.

By 1 mpi, GFP+/DCX+ NBs with the typical immature granule neuron morphology had emerged from the GFP-expressing population ([Figure 3](#fig3){ref-type="fig"}C), demonstrating that some cells that were initially labeled by the split-Cre approach had generated immature neurons by this time (see also [Figures 4](#fig4){ref-type="fig"}A and 4C). Notably, even at 1 mpi, GFAP+ radial and horizontal astrocytes were still the majority of GFP+ cells, further supporting their quiescent nature. Interestingly, in some instances of low-density infection, we observed GFP+ cell clusters, possibly clonally derived cells, consisting of a GFAP+ radial astrocyte in close proximity to a GFAP− cell and several NBs ([Figure 3](#fig3){ref-type="fig"}D).

At 3 mpi, GFP+/GFAP+ cells with radial and horizontal morphology reminiscent of the initial population ([Figure 3](#fig3){ref-type="fig"}H; [Table S1](#app2){ref-type="sec"}) persisted in the SGZ, indicating some degree of self-renewal. We could still detect GFP+ NBs expressing DCX, suggesting that they were recently generated and had not yet fully matured (11%; n = 1680 GFP+ cells, 3 animals; [Figures 3](#fig3){ref-type="fig"}E and 3F; [Table S1](#app2){ref-type="sec"}). Most importantly, many mature GFP+/NEUN+ neurons were observed, accounting for 47% of the GFP+ cells ([Figures 3](#fig3){ref-type="fig"}G and 3H; [Table S1](#app2){ref-type="sec"}), consistent with the further maturation of the NBs generated at earlier stages. Notably, glial cells did not increase in the SGZ and GZ populations, implying that the labeled cells were largely neurogenic even in 5-month-old mice. These results strongly suggest that glial cells coexpressing Prominin1 and hGFAP in the SGZ of the adult DG are long-term neurogenic and self-renewing aNSCs.

It has been shown that physical activity increases neurogenesis by effects on various stages of the lineage ([@bib3; @bib19; @bib31]). To test whether the Prominin1+/hGFAP+ lineage also responds to a running stimulus, mice were housed with free access to running wheels directly after the injection of split-Cre viruses and analyzed at 1 mpi. In agreement with previous findings, the number of newly generated GFP+/DCX+ NBs was more than doubled in the running mice in comparison to the nonrunners ([Figures 4](#fig4){ref-type="fig"}A--4C; [Table S1](#app2){ref-type="sec"}). Thus, SGZ NBs expanded at the expense of non-SGZ glia, whereas the SGZ glia showed no obvious difference. These data demonstrate that the Prominin1+/hGFAP+ lineage reacts to voluntary exercise by increasing the generation of new neurons as previously described for quiescent aNSCs ([@bib19]).

Human Prominin1+/GFAP+ Cells in Human DG {#sec2.4}
----------------------------------------

Because the combination of Prominin1 and GFAP labels NSCs in all neurogenic regions of the mouse brain, we investigated the expression of both markers in the postmortem human brain. hGFAP is expressed by many astrocytes of the human hippocampus. Interestingly, we found a very selective localization of human Prominin1 (hProminin1) along radial and nonradial GFAP+ processes ([Figures 4](#fig4){ref-type="fig"}D--4F) in the human DG. This coexpression was consistently observed irrespective of the age of the subject (between 51 and 87 years; [Figures 4](#fig4){ref-type="fig"}D--4F and [S2](#app2){ref-type="sec"}A--S2C). Thus, the adult human DG also harbored cells coexpressing GFAP and Prominin1, similar to neurogenic regions in other mammalian and nonmammalian vertebrates.

Discussion {#sec3}
==========

During brain development, aNSCs originate from their region-specific embryonic counterparts, suggesting common hallmarks between embryonic and adult radial glial cells. We previously showed that Prominin1 in combination with hGFAP is a highly selective marker for NSCs in the embryonic forebrain and the adult SEZ ([@bib1; @bib25]). Here, we extended this labeling technique to the DG and demonstrated that Prominin1+/hGFAP+ cells are long-term, self-renewing aNSCs that increase the generation of new neurons upon physical activity. These data, together with our expression analysis in human DG samples and the widespread expression of Prominin1 in neurogenic zones of other vertebrates ([@bib13]), strongly suggest that the combinatorial expression of hGFAP and Prominin1 is a widespread marker for NSCs in many species and at different developmental stages.

In comparison with our approach, previous analyses of aNSCs in the DG by different single-marker-labeling strategies had the disadvantage of targeting other cell types in addition to aNSCs (e.g., astrocytes in the brain parenchyma with GLASTCreERT2, as shown in [@bib23]; GFAP-CreERT2, as shown in [@bib10] or GFAPtk, as shown in [@bib20]; or ependymal cells and IPs with Nestin-CreERT2, as shown in [@bib2] and [@bib17]). Likewise, injection of viral vectors (MLV-based Cre retroviruses) largely labels fast-proliferating progenitor cells in the SGZ ([@bib12; @bib35]). Targeting Prominin1/hGFAP-coexpressing cells has the advantage that it avoids initial labeling of IPs and NBs. The ability to follow the aNSC lineage directly from its origin, including radial and nonradial aNSCs while excluding NSC progeny, is an important improvement that allows us to analyze stem cell characteristics and lineage progression under specific conditions (e.g., age, disease, running, and learning).

Interestingly, Prominin1 is found in other adult stem cell populations, such as those in the hematopoietic system and small intestine ([@bib29; @bib36]) and is a marker of tumor-initiating cells in several cancers ([@bib22]). It was originally discovered in humans as an antibody against the AC133 antigen ([@bib28]), a glycosylation-dependent epitope of CD133. Prominin1+ cells isolated from the adult human kidney were shown to be capable of self-renewal and multilineage differentiation, and to contribute to renal tissue regeneration ([@bib4]). Our finding that Prominin1 is expressed in both major sets of adult murine NSCs further supports its widespread presence in adult stem cell populations. Prominin1 has been implicated at the functional level in self-renewal of stem cells ([@bib8]). Its association with cholesterol-based membrane microdomains and protrusion-specific localization led to the hypothesis that Prominin1 plays a role in the biogenesis and functional maintenance of plasma membrane protrusions, and there is evidence that the release of Prominin1-containing membrane particles may contribute to cell differentiation ([@bib5]). Although the function of Prominin1 in embryonic and adult NSCs needs further investigation, here we substantiate the wide applicability of Prominin1 in combination with an additional tissue-specific antigen as a valuable tool for identifying stem cells.

Experimental Procedures {#sec4}
=======================

Animals and Stereotactic Injections {#sec4.1}
-----------------------------------

hGFAP-eGFP ([@bib24]) and CAG CAT GFP reporter ([@bib21]) mice were kept under standard housing conditions. For the voluntary exercise paradigm, running wheels were put in the cages. Experimental procedures were performed in accordance with German and European Union guidelines and were approved by the institutional animal care committee and the Government of Upper Bavaria under license number 55.2-1-54-2531-144/07. Stereotactic injections were performed as previously described ([@bib12]) with 1 μl of virus per DG at the following coordinates: −2.0 anterior/posterior, ±1.6 medial/lateral, and −1.9 to −2.1 dorsal/ventral relative to bregma (in millimeters). Split-Cre viral constructs were as described in [@bib1].

Human Tissue {#sec4.2}
------------

Tissues were procured from patients who were admitted to the Department of Neuropathology, University of Debrecen, Debrecen, Hungary, and died between January and April 2011. The institutional review board and local ethics committee approved the study, and informed consent was obtained from the relatives of all patients analyzed.

Tissue collection (occipital cortex and hippocampus) was performed in subjects without neurological or psychiatric disease who died from nonneurological causes. Brain tissue was frozen and stored at −80°C until further analysis.

Immunohistochemistry {#sec4.3}
--------------------

Animal handling, sectioning of brains, and immunohistochemistry are described in detail in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

The following primary antibodies were used: rat anti-CD133 (1:100; eBioscience), chicken anti-GFP (1:2000; Aves), mouse anti-GFAP (1:500; Sigma), rabbit anti-GFAP (1:500; DAKO), rabbit anti-DCX (1:500; abcam), guinea pig anti-DCX (1:500; Millipore), mouse anti-Nestin (1:200; Millipore), rabbit anti-SOX2 (1:500; Millipore), mouse anti-S100β (1:1000; Sigma), rat anti-BrdU (1:200; Serotec), mouse anti-BrdU (1:200; Becton Dickinson), mouse anti-KI67 (1:200; DAKO), mouse anti-NEUN (1:100; Millipore), rabbit anti-TBR2 (1:500; abcam), rabbit anti-human GFAP (1:1,000; DAKO), and mouse anti-human PROMININ1 (80B258; [@bib14]).

Primary antibodies were visualized with Alexa-conjugated secondary antibodies (all 1:400; Invitrogen). Biotinylated secondary antibodies (1:400; Vector Laboratories) were used in combination with Alexa-conjugated streptavidin (Invitrogen) to enhance CD133 and GFP signals. As a negative control, staining was done using secondary antibody only.

Supplemental Information {#app2}
========================

Document S1. Supplemental Experimental Procedures, Figures S1 and S2, and Table S1
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![Characterization of Cell Types Expressing Prominin1 and hGFAP-eGFP\
(A) Expression of Prominin1 (red) in processes of radial astrocytes (arrowheads), including hGFAP-eGFP+ cells (green; arrows). Prominin1 is not specifically expressed outside the DG (asterisk).\
(B) Colocalization of Prominin1 with GFAP (white) in the SGZ (arrowhead), including those positive for hGFAP-eGFP+ (arrows). Most hGFAP-eGFP+-only cells also express GFAP (double-headed arrow).\
(C) Colocalization of Prominin1 with Nestin (white) in the DG reveals coexpression in all Prominin1+/hGFAP-eGFP+ (arrows) and Prominin1+-only cells (arrowheads).\
(D) Example of Prominin1+/hGFAP-eGFP+ cells negative for DCX (arrow), surrounded by DCX+ cells (white) that weakly express hGFAP-eGFP and are negative for Prominin1 (double-headed arrows).\
(E) Prominin1+/hGFAP-eGFP+ cell (arrow) immunoreactive for SOX2 (white).\
(F) Table summarizing the expression of molecular markers in Prominin1+/hGFAP-eGFP+, Prominin1+/hGFAP-eGFP−, and Prominin1−/hGFAP-eGFP+ cells (three or more animals analyzed per marker). Scale bars, 20 μm.\
See also [Figure S1](#app2){ref-type="sec"}.](gr1){#fig1}

![Prominin1+/hGFAP-eGFP+ Cells Proliferate In Vivo\
(A--E) Confocal images of hGFAP-eGFP in the BrdU pulse-chase paradigm.\
(A) Colocalization of DCX (white) with BrdU in hGFAP-eGFP mice. Note that NBs comprise the majority of all BrdU-label-retaining cells (arrows).\
(B) Example of a GFAP+, BrdU-label-retaining cell (white, arrow).\
(C) BrdU-label-retaining cells in the DG expressing Prominin1 and hGFAP-eGFP (arrows), Prominin1+ only (arrowhead), or hGFAP-eGFP+ only (double-headed arrow).\
(D) Magnified image of a Prominin1+/hGFAP-eGFP+ BrdU-label-retaining cell (arrow labels the soma, arrowhead labels the process).\
(E) Image of a cell positive for hGFAP-eGFP and coexpressing BrdU and the cell-cycle marker KI67 (white; arrow labels the soma, arrowheads label the process). Scale bars, 20 μm.](gr2){#fig2}

![Split-Cre-Based Fate Mapping of Prominin1+/hGFAP-eGFP+ Cells in the DG of Adult GFP Reporter Mice\
(A) Examples of recombined cells at 3 dpi, including GFAP+ radial astrocytes (RG), horizontal astrocytes (HA), and hilus astrocytes (arrow).\
(B) Schematic illustrating recombined cells according to their location and morphology. The pie chart depicts their relative proportions based on immunohistochemical markers and morphological analyses at 3 dpi.\
(C) DCX+ recombined cells at 1 mpi.\
(D) Example of a recombined putative clone consisting of a GFAP+ RG (arrow), an IP, and two GFAP− NBs at 1 mpi.\
(E) Overview of recombined cells in the DG at 3 mpi.\
(F) Magnified image of the boxed area in (E) showing several recombined DCX+ NBs.\
(G) Single-stack image of a recombined NEUN+ mature granule neuron at 3 mpi.\
(H) Same as in (B) at 3 mpi.\
Scale bars, 100 μm (A and E) and 20 μm (C, D, F, and G). GZ, granular zone; ML, molecular layer. See also [Figure S1](#app2){ref-type="sec"} and [Table S1](#app2){ref-type="sec"}.](gr3){#fig3}

![Split-Cre Injections in Running versus Nonrunning Mice, and hProminin/hGFAP Expression in the Human DG\
(A and B) Overview of split-Cre injections in the DG of CAG CAT GFP nonrunning (A) and running (B) mice.\
(C) Pie charts illustrate the relative proportion of recombined cells.\
(D) Expression of hProminin1 (red) in processes of hGFAP+ astrocytes (green) in the human DG (outlined by dotted lines; for further characteristics of the subject, see [Figure S2](#app2){ref-type="sec"}C); magnification of boxed areas in (E and F).\
(E) Colocalization of hProminin1 and hGFAP (arrows) in radially oriented glial cells in the DG as well as in other glial processes (F).\
Scale bars, 100 μm (A and B) and 20 μm (D--F). See also [Figure S1](#app2){ref-type="sec"} and [Table S1](#app2){ref-type="sec"}.](gr4){#fig4}
